HBM BIOVENTURES CAYMAN LTD

10% owner at MICRUS ENDOVASCULAR CORP · on record since Mar 1, 2007
10% owner at Pacira BioSciences, Inc. · on record since Feb 10, 2011
10% owner at Nabriva Therapeutics plc · on record since Dec 30, 2016
10% owner at PTC THERAPEUTICS, INC. · on record since Jun 28, 2013
10% owner at IVERIC bio, Inc. · on record since Sep 24, 2013
10% owner at WAVETRUE, INC. · on record since Nov 5, 2014
10% owner at Apollo Endosurgery, Inc. · on record since Oct 2, 2014
10% owner at ICAGEN INC · on record since Feb 3, 2005
10% owner at Aspreva Pharmaceuticals CORP · on record since Mar 8, 2005
10% owner at Werewolf Therapeutics, Inc. · on record since Apr 29, 2021
10% owner at IO Biotech, Inc. · on record since Nov 12, 2021
10% owner at Mineralys Therapeutics, Inc. · on record since Feb 16, 2023

Insider trading activity of HBM BIOVENTURES CAYMAN LTD

Transactions on record: 553; since Feb 10, 2005

Open-market buys: 225; $61.9M

Open-market sells: 286; $66.8M

Companies traded: 12; last filing Feb 16, 2023

Figures computed from official regulatory filings — .

Companies where HBM BIOVENTURES CAYMAN LTD has traded

Mineralys Therapeutics, Inc.5 tx · $5M · Feb 16, 2023
IO Biotech, Inc.3 tx · $4.6M · Nov 12, 2021
Werewolf Therapeutics, Inc.2 tx · May 5, 2021
36 tx · $4.1M · Sep 14, 2017
10 tx · $1.8M · Jul 21, 2017
4 tx · $632.9K · Jun 1, 2015
10 tx · $19.9M · May 15, 2014
6 tx · $11.3M · Dec 19, 2013
13 tx · $53.1M · Mar 25, 2013
451 tx · $14M · Mar 4, 2010
7 tx · $28.1M · Mar 17, 2005
6 tx · Feb 10, 2005

Track record of HBM BIOVENTURES CAYMAN LTD

Statistical track record

Free account

Open-market buys: 225

Last buy: Feb 14, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of HBM BIOVENTURES CAYMAN LTD

Co-insiders of HBM BIOVENTURES CAYMAN LTD

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	OtherD (derivative)	-10,411,846	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	OtherD (derivative)	-20,962,895	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	Other	1,941,368	—	n/a (No price was disclosed in the filing)		SEC
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	Buy	312,500	16.00 USD	$5M	conv 53ClusterFirst in 12mo	SEC
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	Other	964,238	—	n/a (No price was disclosed in the filing)		SEC
IO Biotech, Inc.Listing unverified	Nov 12, 2021	Buy	325,000	14.00 USD	$4.6M	conv 53ClusterFirst in 12mo	SEC
IO Biotech, Inc.Listing unverified	Nov 12, 2021	Other	2,365,545	—	n/a (No price was disclosed in the filing)		SEC
IO Biotech, Inc.Listing unverified	Nov 12, 2021	OtherD (derivative)	-188,168	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Werewolf Therapeutics, Inc.Listing on record	May 5, 2021	OtherD (derivative)	5,426,819	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Werewolf Therapeutics, Inc.Listing on record	May 5, 2021	Other	625,995	—	n/a (No price was disclosed in the filing)		SEC
Nabriva Therapeutics plcListing unverified	Sep 14, 2017	Sell	-3,429	8.52 USD	$29.2K		SEC
Nabriva Therapeutics plcListing unverified	Sep 14, 2017	Sell	-22,721	8.54 USD	$194K		SEC
Nabriva Therapeutics plcListing unverified	Sep 14, 2017	Sell	-10,458	8.63 USD	$90.3K		SEC
Nabriva Therapeutics plcListing unverified	Sep 5, 2017	Sell	-639	9.50 USD	$6.1K		SEC
Nabriva Therapeutics plcListing unverified	Aug 9, 2017	Sell	-17,790	10.50 USD	$186.8K		SEC
Nabriva Therapeutics plcListing unverified	Aug 9, 2017	Sell	-2,013	10.50 USD	$21.1K		SEC
Nabriva Therapeutics plcListing unverified	Aug 1, 2017	Sell	-6,585	10.51 USD	$69.2K		SEC
Nabriva Therapeutics plcListing unverified	Jul 26, 2017	Sell	-160	10.50 USD	$1.7K		SEC
Nabriva Therapeutics plcListing unverified	Jul 24, 2017	Sell	-23,445	10.50 USD	$246.2K		SEC
Nabriva Therapeutics plcListing unverified	Jul 24, 2017	Sell	-20,786	10.50 USD	$218.3K		SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 21, 2017	Sell	-23,445	10.50 USD	$246.2K		SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 21, 2017	Sell	-20,786	10.50 USD	$218.3K		SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 18, 2017	Sell	-47,460	10.50 USD	$498.3K	Unusual size	SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 18, 2017	Sell	-21,055	10.53 USD	$221.7K		SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 18, 2017	Sell	-1,339	10.50 USD	$14.1K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	OtherD (derivative)	-10,411,846	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	OtherD (derivative)	-20,962,895	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	Other	1,941,368	—	n/a (No price was disclosed in the filing)		SEC
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	Buy	312,500	16.00 USD	$5M	conv 53ClusterFirst in 12mo	SEC
Mineralys Therapeutics, Inc.Listing on record	Feb 16, 2023	Other	964,238	—	n/a (No price was disclosed in the filing)		SEC
IO Biotech, Inc.Listing unverified	Nov 12, 2021	Buy	325,000	14.00 USD	$4.6M	conv 53ClusterFirst in 12mo	SEC
IO Biotech, Inc.Listing unverified	Nov 12, 2021	Other	2,365,545	—	n/a (No price was disclosed in the filing)		SEC
IO Biotech, Inc.Listing unverified	Nov 12, 2021	OtherD (derivative)	-188,168	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Werewolf Therapeutics, Inc.Listing on record	May 5, 2021	OtherD (derivative)	5,426,819	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Werewolf Therapeutics, Inc.Listing on record	May 5, 2021	Other	625,995	—	n/a (No price was disclosed in the filing)		SEC
Nabriva Therapeutics plcListing unverified	Sep 14, 2017	Sell	-3,429	8.52 USD	$29.2K		SEC
Nabriva Therapeutics plcListing unverified	Sep 14, 2017	Sell	-22,721	8.54 USD	$194K		SEC
Nabriva Therapeutics plcListing unverified	Sep 14, 2017	Sell	-10,458	8.63 USD	$90.3K		SEC
Nabriva Therapeutics plcListing unverified	Sep 5, 2017	Sell	-639	9.50 USD	$6.1K		SEC
Nabriva Therapeutics plcListing unverified	Aug 9, 2017	Sell	-17,790	10.50 USD	$186.8K		SEC
Nabriva Therapeutics plcListing unverified	Aug 9, 2017	Sell	-2,013	10.50 USD	$21.1K		SEC
Nabriva Therapeutics plcListing unverified	Aug 1, 2017	Sell	-6,585	10.51 USD	$69.2K		SEC
Nabriva Therapeutics plcListing unverified	Jul 26, 2017	Sell	-160	10.50 USD	$1.7K		SEC
Nabriva Therapeutics plcListing unverified	Jul 24, 2017	Sell	-23,445	10.50 USD	$246.2K		SEC
Nabriva Therapeutics plcListing unverified	Jul 24, 2017	Sell	-20,786	10.50 USD	$218.3K		SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 21, 2017	Sell	-23,445	10.50 USD	$246.2K		SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 21, 2017	Sell	-20,786	10.50 USD	$218.3K		SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 18, 2017	Sell	-47,460	10.50 USD	$498.3K	Unusual size	SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 18, 2017	Sell	-21,055	10.53 USD	$221.7K		SEC
Nabriva Therapeutics Legacy plcListing unverified	Jul 18, 2017	Sell	-1,339	10.50 USD	$14.1K		SEC